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Bis-indolylquinones represent a class of fungal
natural products that display antiretroviral,
antidiabetes, or cytotoxic bioactivities. Recent
advances in Aspergillus genomic mining efforts
have led to the discovery of the tdiA-E-gene
cluster, which is the first genetic locus dedi-
cated to bis-indolylquinone biosynthesis. We
have nowgenetically and biochemically charac-
terized the enzymes TdiA (bis-indolylquinone
synthetase) andTdiD (L-tryptophan:phenylpyru-
vate aminotransferase), which, together,
confer biosynthetic abilities for didemethylas-
terriquinone D to Aspergillus nidulans. This
compound is the universal intermediate for
all bis-indolylquinones. In this biochemical
study of a bis-indolylquinone synthetase and
a fungal natural product transaminase, we
present a one-pot chemoenzymatic protocol
to generate didemethylasterriquinone D
in vitro. As TdiA resembles a nonribosomal
peptide synthetase, yet catalyzes carbon-
carbon-bond formation, we discuss the impli-
cations for peptide synthetase chemistry.
INTRODUCTION
Filamentous fungi represent a proven source for small-
molecule drug lead structures that interact with various
cellular targets [1]. Among fungal secondary metabolites,
the bis-indolylquinone family of compounds has received
close attention for three distinct bioactivities. First, cyto-
toxic effects in the submicromolar range, found in murine
leukemia cell assays. This was shown for asterriquinone
and derivatives [2]. Secondly, antiretroviral activity, e.g.,
anti-HIV activity, was found for didemethylasterriquinone
D (DDAQ D), isocochliodinol, semicochliodinols A and B,
and hinnuliquinone [3, 4] (Figure 1). These fungal natural
products inhibit HIV-1-protease at concentrations of
about 100–500 nM. The third bioactivity pertains to the
antidiabetes activity of L 783,281 (didemethylasterriqui-
none B1) [5, 6] as this compound acts agonistically on
the insulin receptor. Given the oral availability of this com-Chemistry & Biology 14, 63pound, this finding prompted increased interest in the
bis-indolylquinones; protocols for their chemical synthesis
were devised [7, 8]. The accepted hypothesis on bis-
indolylquinone biosynthesis put forth by Arai and
Yamamoto [9] includes deamination of L-tryptophan to
indole-3-pyruvic acid, which feeds into a dimerization
reaction to yield DDAQ D. This symmetric compound
represents the generic intermediate en route to numerous
derivatives, including the aforementioned compounds,
whose pathways diverge due to regiospecific transfers
of prenyl groups, the most prominent structural decora-
tions of bis-indolylquinones. The C- or N-prenyltransfer
reactions may occur symmetrically or disturb molecular
symmetry by transfer of one single prenyl unit or two units
to different acceptor positions.
More recently, the first genetic locus for a bis-indolyl-
quinone metabolic pathway, the tdiA-E gene cluster
(Figure 2) for terrequinone A, was discovered in the ge-
nome of the filamentous fungus Aspergillus (A.) nidulans
applying genomic and chemical analyses along with
microarray techniques [10]. Intriguingly, the translational
products of two genes, tdiD and tdiA, resemble transam-
inases and an adenylation-thiolation-thioesterase/
cyclase domain triad, respectively, the latter reminiscent
to nonribosomal peptide synthetase (NRPS) domains.
Based on these in silico analyses, we hypothesized
that TdiD and TdiA could provide the key catalytic
activities to expand the shikimic acid pathway beyond
L-tryptophan toward DDAQ D.
In this publication, we report the genetic and biochemi-
cal characterization of the tdiD- and tdiA-encoded
enzymes from A. nidulans, which represent the prototypi-
cal transaminase and bis-indolylquinone synthetase,
respectively, for this class of natural products. To our
knowledge, this is the first characterization of a bis-
indolylquinone synthetase and a fungal natural product
transaminase. Based on these results, we demonstrate
a coupled TdiD/TdiA enzymatic one-pot reaction as a
platform technology to provide the universal precursor
for numerous bioactive bis-indolylquinones.
RESULTS
Sequencing of tdiA and tdiD cDNAs
The experimentally verified DNA-sequences for tdiA and
tdiD deviate substantially from the predicted sequences5–644, June 2007 ª2007 Elsevier Ltd All rights reserved 635
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Bis-Indolylquinone Biosynthetic EnzymesFigure 1. Chemical Structures of Bioactive Fungal Bis-Indolylquinones
Biosynthetic steps catalyzed by TdiA and TdiD are also shown.deposited on the BROAD server [11], which relies on
automatic computer-based gene annotation. For tdiA,
a 63 bp intron is erroneously predicted in the 30-terminal
portion of the reading frame. Our results prove that tdiA
is one continuous, intronless 2913 bp reading frame that
codes for a 970 aa protein with a calculated mass of
107.6 kDa, which clearly presents sequence motifs for
adenylation, peptidyl carrier, and thioesterase domains
Figure 2. Organization of the Terrequinone A Biosynthetic
Locus in Aspergillus nidulans
Black arrows indicate the transcriptional direction and symbolize the
genetic cluster. Open arrows represent genes outside the cluster.
The modular architecture of the tdiA gene product is highlighted by
abbreviations: A (adenylation domain), PCP (peptidyl carrier protein),
TE (thioesterase/cyclase).636 Chemistry & Biology 14, 635–644, June 2007 ª2007 Elseviof NRPSs, as described by Marahiel and coworkers [12]:
in TdiA, the thioesterase core motif 772GYSFG776 follows
exactly the consensus GxSxG, the peptidyl carrier protein
(PCP) motif slightly deviates from the canonical sequence
LGG(D/H)SL and is represented by 627IGATSM632. Of
particular interest in our context was the adenylation do-
main, whose key residue amino acid 235 (according to
PheA numbering) in core motif A4 [12] indicative for either
amino (D235) or arylic (N235) acid activation replaced by
a valine (V239) in TdiA (Table 1). Also, position 239 (in
PheA numbering) was used in the past to discriminate di-
hydroxybenzoate (S239) from salicylate (C239) activating
A-domains. This position, in turn, aligns with H244 in
TdiA. It should be noted, however, that a cystein is resid-
ing at position 245.
We also report an updated tdiD sequence. By errone-
ously joining two adjacent contigs, 1.154 and 1.155,
head to tail (rather than overlapping these), the gene
tdiD was duplicated and, consequently, presented twice
in the genome database as reading frames AN8516.3
and AN8519.3, both times annotated as ‘‘hypothetical
gene.’’ Confusingly, these sequences are not identical.
Our tdiD cDNA sequence confirms AN8519.3 as correcter Ltd All rights reserved
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Bis-Indolylquinone Biosynthetic EnzymesTable 1. ClustalWAlignment of theAdenylationDomainPortion aroundCoreMotif A4 for TdiA, Its Homologs Found in
Microbial Genomes, and Aryl Acid Adenylation Domains
Position Enzyme
230 F L S WVH MDHV ANL V HC H I F A I TdiA (A. nid.)
TdiA homologs
218 T L NWI S F DHV AA L L E A H L L P L R. sol.
217 F Y NWVGL DHV AS L T E I H L H A L A. nid.
233 F L S WVH MDHV ANL V HC H L F A I A. ter.
221 F MS WVN MDHV ANL V HC H L F A I C. glob.(1)
248 F L NWI GL DHV AS L V E MH I QA L C. glob.(2)
236 F L S WVS F DHS AA L CE N H L H A V P. nod.
Aryl acid adenylation
213 YL CA L P V A HNF P L ACP GI L GT YbtE
230 F L CA L P T A HNYP MS S P GAL GV EntE
228 YL A A L P I A HNYP L S S P GV L GT DhbE
The positions N235 and C239 (according to PheA numbering) are highlighted in bold. R. sol.: NP_522978 from Ralstonia
solanacearum. In the shown region, the enzyme is identical to Burkholderia pseudomallei (accession number: YP_110151).
A. nid.: AN3392.3 from Aspergillus nidulans. A. ter.: XP_001210786 from Aspergillus terreus NIH2624. C. glob. (1): XP_001230203
fromChaetomium globosumCBS 148.51.C. glob. (2): XP_001228818 from the same fungus.P. nod.: EAT88825 from Phaeosphae-
ria nodorum SN15. YbtE adenylates salicylic acid during yersiniabactin biosynthesis in Yersinia pestis, and EntE and DhbE adeny-
late 2,3-dihydroxybenzoic acid in the enterobactin pathway of Escherichia coli and the bacillibactin pathway of Bacillus subtilis,
respectively.version and also the existence of the 12 bp exon after base
435, which was lacking in the previous version AN8519.2
(and still is in AN8516.3). Therefore, tdiD represents
a 1311 bp reading frame coding for a predicted 436 aa,
47.7 kDa member of the PLP-dependent aminotransfer-
ase family.
Gene Inactivations
The terrequinone A biosynthetic genes were predicted
during a genome-wide screen for genes under regulation
of the transcriptional regulator protein LaeA, which
controls genes and even gene clusters dedicated to
secondary metabolism [10, 13]. Prior to our biochemical
investigations, we first verified involvement of tdiA and
tdiD in this pathway and inactivated these genes by
replacing them with the pyroA selection marker.
Inactivation of tdiD was accomplished by transforma-
tion of A. nidulans TN02A7 with the linear 4.5 kb EcoRI/
HindIII insert of inactivation plasmid pKR2 to replace
tdiD with a pyroA cassette. This manipulation eliminated
the entire tdiD gene and 20 bp upstream of ATG and
resulted in strain TMW3.7. Proper gene replacement
was confirmed by Southern hybridization (not shown).
A. nidulans produces two major, yet unrelated, metabo-
lites, terrequinone A and sterigmatocystin, the latter being
an aromatic polyketide and penultimate intermediate of
the aflatoxin pathway. Upon comparison of the natural
product spectrum of TMW3.7 versus the parental strain
by HPLC and LC/MS, no variation in sterigmatocystin
production was observed (Figure 3A). However, terrequi-
none A was only present in very moderate quantities inChemistry & Biology 14, 6TMW3.7 yet unambiguously identifiable by LC/MS and
by its UV-VIS spectrum. We therefore concluded that
TdiD plays an important role for terrequinone A biosyn-
thesis, although A. nidulans seems to harbor an enzyme
that—albeit poorly—can complement the DtdiD geno-
type. We complemented A. nidulans TMW3.7 by transfor-
mation with plasmid pMW9 to introduce an intact tdiD
copy back into the genome, to create strain TMW8.3.
This complementation event restored terrequinone A
biosynthesis close to wild-type level, as shown by HPLC
(Figure 3A).
The tdiA inactivation was carried out in A. nidulans
rNI773 by protoplast transformation with the linear
4.6 kb EcoRI/HindIII insert of inactivation plasmid pKR1,
which deleted 43 bp upstream and 2351 bp within the
tdiA reading frame and resulted in the DtdiA mutant
TMW1.2, which was confirmed by Southern analysis as
well (not shown). Inactivation of tdiA disabled terrequinone
production quantitatively, and not even traces were
detectable in HPLC chromatograms, while the sterigma-
tocystin production in the DtdiA-strain did not change
(Figure 3A).
Enzyme Characterization
After tdiA and tdiD had experimentally been verified as
part of the terrequinone biosynthetic cascade, we pro-
duced soluble TdiA- and TdiD-hexahistidine fusion pro-
teins (Figure 4) in E. coli BL21(DE3) 3 pLysS transformed
with plasmids pDH8 and pDH9, respectively. These
expression plasmids harbor the corresponding cDNAs.35–644, June 2007 ª2007 Elsevier Ltd All rights reserved 637
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(A) Natural product analyses of A. nidulans
strains TN02A7 (WT), TMW3.7 (DtdiD), TMW8.3
(tdiD complementation), rNI773 (WT), and
TMW1.2 (DtdiA), recorded at 280 nm. Sterig-
matocystin elutes after 8.8 min, terrequinone
A after 11.1 min, when applying the solvent
gradient described in the Experimental
Procedures.
(B) Authentic references: L-tryptophan (L-trp,
retention time 5.9 min), indole-3-pyruvate
(I3P, retention time 2.1 min), and di-demethyl-
asterriquinone D (DDAQ D, retention time
6.6 min).
(C) Enzyme assays: coupled two-enzyme one-
pot reaction (TdiA + TdiD), and single enzyme
assays for TdiA and TdiD, respectively. APCI-
MS traces (negative mode) are given for
DDAQ D (M-H+ = 369), L-tryptophan (L-Trp,
M-H+ = 203), and indole-3-pyruvate (I3P,
M-H+ = 202). Lines indicate the corresponding
chromatographic peaks.As the amino acceptor substrate for TdiD was unknown,
we first tested a panel of a-keto acids, guided by charac-
terized transaminases—mainly of nonfungal origin—
involved in tryptophan degradation or natural product
pathways, e.g., from Agrobacterium tumefaciens [14],
the indolmycin producer Streptomyces griseus [15], Cory-
nebacterium glutamicum [16] and Neurospora crassa [17],
or from the mosquito Anopheles gambiae [18]. The tested
amino acceptor substrates included pyruvic acid, 2-oxo
glutaric acid, 2-oxo-butyric acid, 2-oxo-valeric acid, 4-638 Chemistry & Biology 14, 635–644, June 2007 ª2007 Elseviehydroxy-phenylpyruvic acid, and phenylpyruvic acid. Sig-
nificant transaminase activity with L-tryptophan as amino
group donor was only detected in the presence of phenyl-
pyruvic acid as amino acceptor, while all other com-
pounds failed as adequate substrates and resulted in
<5% indole-3-pyruvic acid formation, except 4-hydroxy-
phenylpyruvic acid, which resulted in 15% conversion,
compared to phenylpyruvic acid. Therefore, we report
TdiD as the L-tryptophan:phenylpyruvate aminotransfer-
ase (EC 2.6.1.28), which catalyzes the first enzymaticr Ltd All rights reserved
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none A (Figure 5A). To our knowledge, TdiD is the first
fungal natural product transaminase to be characterized
biochemically. The optimal temperature and pH value for
TdiD was determined in vitro by product formation and
assessed by HPLC. We found optimal product formation
at 48C, which appears somewhat out of the physiological
range for an ubiquitous filamentous fungus, although even
higher in vitro temperature optima have been reported for
other transaminases [14, 18]. Further reactions were thus
maintained at 48C. Catalytic activity of TdiD was deter-
mined in 100 mM phosphate buffer at pH values ranging
from 5.7 to 8.0. Optimal activity was observed at neutral
pH, and no differences were found when the buffer was
substituted for Tris-HCl. Kinetics characteristics are
Km = 3.02 ± 0.61 mM and kcat = 1157 (± 104)/min for
L-tryptophan; for phenylpyruvic acid, Km = 1.43 (± 0.44)
mM and kcat = 548 (± 67)/min was found.
Although a big array of microbial adenylating enzymes
has been investigated—the majority as integral domains
of bacterial multimodular NRPSs for natural product or
siderophore biosynthesis—the biochemistry of a bis-
indolylquinone synthetase has not been described yet.
Our strategy to investigate TdiA followed a two-step
approach. First, we relied on the ATP-PPi exchange assay
to verify activity of heterologously expressed apo-TdiA
and to record pH and temperature optimum. Optimal
adenylation of indole-3-pyruvic acid took place at 42C
and at pH 6.5, although a plateau of >80% relative activity
was identified for the range pH 6.0 to 7.0.
In a second step, we produced holo-TdiA through enzy-
matic phosphopantetheinyl (Ppant) transfer, catalyzed by
the Ppant transferase Svp taken from the gram-positive
soil bacterium Streptomyces verticillus, the producer of
the antitumor drug bleomycin [19]. Holo-TdiA was
Figure 4. Electrophoretic Analysis of Heterologously Ex-
pressed Proteins
Hexahistidine-tagged enzymes TdiA (left lane, calculated mass:
107.6 kDa) and TdiD (right lane, calculated mass: 47.7 kDa) after
SDS-polyacrylamide gel electrophoresis (12% Laemmli gel). Molecu-
lar weight markers on the center lane are (top to bottom) 97, 66, and
45 kDa, respectively.Chemistry & Biology 14,employed to demonstrate product formation, i.e., DDAQ
D, (Figure 5B) which was identified in HPLC analyses by
its UV-spectrum, by mass spectrometry, and by compari-
son with an authentic sample (Figures 3B and 3C). Kinetics
of TdiA were determined under optimal conditions
reported above by measuring DDAQ D formation, and we
found that holo-TdiA followed a typical Michaelis-Menten
kinetic for indolepyruvic acid and saturating concentra-
tions of ATP. The Km value for indole-3-pyruvic acid was
Km = 1.16 ± 0.22 mM. The kcat value was determined as
kcat = 69.9 ± 5.33/min. These results prove that TdiA pos-
sesses activity to cyclize monomeric indole-3-pyruvate
into a quinoid structure. Moreover, we prove compatibility
of the bacterial Svp with the fungal peptidyl carrier protein.
One-Pot Synthesis of Di-Demethylasterriquinone D
After optimal conditions were established for either
enzyme, we explored the possibility of a combined two-
step reaction to synthesize DDAQ D from two inexpensive
substrates, L-tryptophan and phenylpyruvic acid. For
indole-3-pyruvic acid, costs per mol are about 10-fold
above those for phenylpyruvic acid and L-tryptophan
(and pyridoxal 5-phosphate as cofactor) combined. This
is why we sought to feed enzymatically generated
indole-3-pyruvic acid into the process and why we did
not simply rely on TdiA to synthesize DDAQ from indole-
3-pyruvic acid.
Optimal synthesis of DDAQ D, mediated by the
enzymes TdiD and TdiA, took place at 42C in Tris-HCl
buffer at pH 6.5. We used a 2-fold excess of phenylpyruvic
acid as amino acceptor substrate of TdiD. In our pilot
study, we found a 21% yield (a theoretical 100% yield
would be the quantitative conversion of 2 mM L-trypto-
phan into 1 mM DDAQ D), as estimated by HPLC and
Figure 5. Reaction Schemes
The metabolic steps catalyzed by (A) the transaminase TdiD and (B) by
the bis-indolylquinone synthetase TdiA constitute the initial events
during bisindolylquinone biosynthesis.635–644, June 2007 ª2007 Elsevier Ltd All rights reserved 639
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Like above, authentic DDAQ D served as standard (Fig-
ures 3B and 3C).
DISCUSSION
In this publication, we report on the identification of
Aspergillus nidulans TdiA as bis-indolyl-benzoquinone
synthetase and of TdiD as an L-tryptophan:phenylpyruvic
acid transaminase (Figure 5) along with their use for
chemoenzymatic synthesis of didemethylasterriquinone
D, the key precursor for the whole class of bis-indolylqui-
nones, which is a class of cytotoxic, antidiabetes, and
antiviral natural products.
Our in vitro studies clearly presented TdiD as the L-
tryptophan:phenylpyruvate transaminase, whose bio-
chemical properties and kinetic values are in good
accordance with data available from the literature [14,
18]. This holds for the elevated temperature optimum of
48C as well. As assessed by HPLC analyses, inactivation
of the tdiD gene did not completely disrupt terrequinone
A biosynthesis. As transamination is a crucial process
during primary metabolism as well, e.g., during amino
acid biosynthesis or breakdown, a presence of a second
sufficiently flexible transaminase may account for the
presence of basal cellular levels of indole-3-pyruvic acid,
which supply TdiA with substrate. Upon searching the
A. nidulans genome for further putative transaminase
genes similar to tdiD, two clear hits (AN6338.2 and
AN5041.3) were returned, both of which do not seem to
be located in the obvious vicinity of genes dedicated to
secondary metabolite production. Also, the otaA gene
(AN1810.2) for the ornithine/acetylornithine aminotrans-
ferase ArgD involved in arginine biosynthesis in A. nidu-
lans has been characterized yet not investigated for any
tryptophan desaminase activity [20].
Promoted by fungal genomics, the past few years have
seen identification of a wealth of fungal NRPS genes, e.g.,
24 in Aspergillus flavus and 14 in A. fumigatus [21], or 11 in
Cochliobolus heterostrophus (including the NRPS-polyke-
tide synthase hybrid NPS7) [22]. This is in sharp contrast
to the few fungal NRPSs that have been investigated bio-
chemically, among those LPS2, which adenylates D-lyser-
gic acid during ergotamine assembly [23], SimA of the
cyclosporin pathway [24], GliP responsible for the glio-
toxin skeleton [25], and the enniatin synthetase Esyn1
[26]. However, no data has been available at all for the
class of C-domainless bis-indolylquinone synthetases.
Also, TdiA-catalyzed dimerization of indole-3-pyruvic
acid into a quinoid structure demonstrates carbon-carbon
bond formation, which, in turn, implicates a novel chemis-
try for NRPSs: we assume a mechanism that follows
a Claisen-type condensation with a nucleophilic attack
on the thioester of the PCP-bound indole-3-pyruvate
monomer by the enolate of a TE-bound indole-3-pyruvate,
to establish the intermolecular C-C-bond between the two
monomers. An intramolecular Dieckmann-condensation
completes quinone formation and releases DDAQ D
from the enzyme.640 Chemistry & Biology 14, 635–644, June 2007 ª2007 ElseviThe ‘‘nonribosomal code,’’ i.e., the specificity-confer-
ring amino acid residues within the A-domain, remains
to be determined. Yet, one would expect TdiA to follow
a signature typical to aryl acid activating A-domains,
such as DhbE (2,3-dihydroxybenzoate adenylation for
bacillibactin biosynthesis in Bacillus subtilis) [27], or
YbtE, a Yersinia pestis salicyl-AMP ligase [28]. Protein
crystallography revealed the invariant aspartic acid resi-
due in the core motif A4 (YxFDxS) of amino acid-AMP
ligases serves to stabilize the a-amino group [29]. Further,
this particular position was identified as instrumental to
distinguish amino acid from arylic acid-AMP ligases,
which possess a neutral asparagine residue instead
(N235 in PheA terminology). Our sequence alignment
identified residues and positions that follow neither the
canonical amino acid signature nor the arylic acid ‘‘finger-
print’’ as the position in question is occupied by a valine
(V239 in TdiA). However, assuming two gaps preceding
motif A4, D237 of TdiA would align with ‘‘N235’’ residues
in DhbE and EntE and confusingly indicate an amino
acid signature. The core motif A4 in TdiA would then be
represented by 236VHMDHV239, and the C245 residue
would be moved further away from the salicylate/
dihydroxybenzoate discriminating position (C/S239) if
aligned with aryl acid activating domains. The TdiA A-
domain amino acid sequence is markedly longer than its
DhbE and YbtE counterparts: counting from N235 in
DhbE (N222 in YbtE) as part of core motif A4, the hydro-
phobic end of core motif A6 (ARGYL) is 128 amino acid
residues away, while TdiA possesses 151 amino acids.
Therefore, the TdiA main chain may account for a
structural situation in this critical portion that substantially
deviates from DhbE or YbtE, and the computer-based
results may reflect a suboptimal alignment that does not
accurately bring structurally corresponding residues of
TdiA and DhbE or YbtE into register. Eventually, only
crystallographic studies can resolve this disparity and
may shed more light on the specifics of the fungal non-
ribosomal code and the relevance of the cystein residue
at position 245.
Homologs of tdiA and/or tdiD exist in numerous fungi
and bacteria, including Aspergillus terreus, which harbors
five tdiA homologs (XP_001210786, XP_001211182,
XP_001217485, XP_001211993, and XP_001212741),
Aspergillus nidulans itself (AN3396.3, a tdiA paralog),
Chaetomium globosum, an allergenic ascomycete, which
possesses tdiA and tdiD homologs clustered at the same
chromosomal locus (XP_001230202 and XP_001230203),
and a second tdiA homolog outside this locus
(XP_001228818). Phaeosphaeria nodorum, an ascomy-
cete that causes blotch disease in cereals, carries tdiA
and tdiD homologs (EAT88825 and EAT88019, respec-
tively). Ralstonia solanacearum is a devastating bacterial
pathogen causing the bacterial wilt on solanaceous crops,
such as potato, tomato, tobacco, and on other agricultur-
ally important plants. This pathogen is of quarantine
importance and object of rigorous pest response plans.
R. solanacearum harbors a tdiA homolog (NP_522978),
separated by four reading frames from the putativeer Ltd All rights reserved
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metabolite gene cluster. Finally, Burkholderia pseudomal-
lei, a bacterial pathogen in humans and causative agent of
melioidosis, possesses a tdiA homolog (YP_336801).
Alignments of the adenylation-domain motif A4 region of
selected homologs are shown in Table 1. Although no
literature is available, an enzymatic tandem of TdiA and
TdiD orthologs can be envisioned as basis for the bio-
synthetic route toward terphenylquinone pigments in
wood-rotting or mycorrhiza-forming basidiomycetes, as
earlier feeding experiments with radiolabeled subs-
tances proved tyrosin and phenyllactic acid as precursors
[30–32]. Taken together, TdiA and TdiD may serve as
model enzymes for broadly distributed biosynthetic
principles of secondary metabolism in commercially and
agriculturally relevant microbes, beyond the class of
bis-indolylquinones.
Multimodular enzymes, such as polyketide synthases or
NRPSs rely on posttranslational phosphopantetheinyla-
tion (also referred to as priming) to convert the apo-
protein, i.e., acyl-, aryl-, or peptidyl carrier domains into
the functional holo-forms [33]. This priming is accom-
plished by dedicated Ppant transferases, which use coen-
zyme A as donor substrate. In this paper, we also demon-
strate that the prokaryotic Ppant transferase Svp from
Streptomyces verticillus ATCC15003, whose cellular
function is priming the bleomycin NRPS, is promiscuous
enough to convert the fungal apo-bis-indolylquinone
synthetase TdiA into its holo-form. To our knowledge,
this is the first demonstration of priming a eukaryotic
NRPS-like enzyme with a prokaryotic PPtase. Also, our
in vitro chemoenzymatic synthesis of di-demethylasterri-
quinone D represents the minimal variant of a hybrid
Streptomyces-Aspergillus pathway and may stimulate
research to expand the repertoire of combinatorial biosyn-
thesis beyond the realm of actinomycete metabolites.
Enzymes from streptomycetes and other prokaryotic
sources have successfully been used in pharmaceutical
chemistry, as exemplified by in vitro glycorandomizing
novel anticancer and antibiotic compounds, such as
calicheamicin and vancomycin [34, 35], or in vivo ap-
proaches, as demonstrated for novobiocin [36]. Although
the metabolic and structural wealth of fungal secondary
metabolism is undoubted, we notice a paucity of efforts
to tap into their rich reservoir of natural product enzymes
for pharmaceutical purposes. This is even more surprising
as a range of other fungal enzymes have found prominent
places in biotechnology, e.g., laccases [37], dehydroge-
nases and lipases [38], or pyranose-2-oxidases [39].
Previous efforts to obtain bis-indolylquinones included
either microbial fermentation [3, 4] or total synthesis. In
either case, multistep purification procedures cannot be
bypassed to remove byproducts or media ingredients.
Protocols to synthesize bis-indolylquinones have been
published [7, 8, 40, 41]. However, these routes lead to
specific compounds—as does microbial fermentation of
fungal producer strains—and do not serve as a platform
technology from which to diverge toward as many differ-
ent compounds as possible. In contrast, our protocolChemistry & Biology 14, 6replicates the naturally occurring cascade and provides
the pivotal intermediate toward a maximum diversity in
terms of chemical structure and pharmacological activity
via a facile two-step chemoenzymatic synthesis. Present
efforts in our lab revolve around process scale-up and
adding the diversifying prenyltransferase step, e.g., using
the enzyme TdiB as a first proof of principle. Its gene is
encoded in the A. nidulans terrequinone locus, it likely
functions as a prenyltransferase, and is similar to a number
of fungal prenyltransferases acting on indole-like struc-
tures. Many of them have already been characterized,
and their genes have been cloned (reviewed in [42]).
Sequence and biochemical information accumulating
from these studies combined with increasingly sophisti-
cated genomic mining techniques allow for identifying
more prenyltransferase genes from a variety of species.
Therefore, our technology presented here represents a
viable route toward a multitude of candidate compounds
in drug development.
SIGNIFICANCE
Due to diverse bioactivities, such as antiretroviral,
antidiabetes, or cytostatic, fungal bis-indolylquinones
represent an attractive class of fungal natural prod-
ucts. The first genetic locus for this class of secondary
metabolites, the tdi-locus for terrequinone A biosyn-
thesis in the filamentous fungus Aspergillus nidulans,
has recently emerged through combined analytic,
genomic, and transcriptomic efforts. In this publica-
tion,we report on the genetic and biochemical charac-
terization of two enzymes: TdiD catalyzes the commit-
ting step during terrequinone A assembly, which is the
transfer of an amino group from L-tryptophan onto
phenylpyruvate. We also identified TdiA as bisin-
dolyl-benzoquinone synthetase. The TdiA-catalyzed
reaction implies new chemistry for NRPS-like en-
zymes due to C-C bond formation. By priming (i.e.,
transfer of a phosphopantetheinyl moiety) TdiA with
the Streptomyces phosphopantetheinyl transferase
Svp, we have demonstrated the feasibility of hybrid
pathways with enzymes taken from the most impor-
tant prokaryotic and most important eukaryotic
source organisms of natural products. Also, as tdiA
and tdiD homologs are found in the genomes of nu-
merous other prokaryots and fungi, our results may
provide a key to cryptic biosynthetic capabilities in
a variety of microorganisms, among those clinically
relevant human or crop plant pathogens. In this bio-
chemical study of a bis-indolylquinone synthetase
and a fungal natural product transaminase, we also
present a one-pot two-enzyme chemoenzymatic
route to di-demethylasterriquinone D—the universal
intermediate for all bis-indolylquinones. This result
provides a platform that is ready to be developed to-
ward numerous members of this class of compounds
with different bioactivities by simply adding specific
tailoring enzymes, above all prenyltransferases, to
the process.35–644, June 2007 ª2007 Elsevier Ltd All rights reserved 641
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General
Chemicals were purchased from Fluka, Sigma-Aldrich, and Roth.
32P-labeled sodium phosphate (80.47 Ci/mmol) was obtained from
PerkinElmer. Standard molecular biology procedures were performed
as described [43]. Isolation of plasmid DNA from E. coli, and DNA
restriction/ligation followed the protocols of the manufacturers of
kits, enzymes, and reagents (Amersham-Pharmacia, Macherey-Nagel,
Promega). Fungal strains are listed in Table S1 (see the Supplemental
Data available with this article online).Aspergillus strains were routinely
grown at 37C on glucose minimal medium (GMM) [44] amended with
appropriate supplements to maintain auxotrophs [45].
Genetic Manipulation of Aspergillus nidulans
The tdiA and the tdiD genes were inactivated separately and by dis-
rupting the reading frame with linear constructs coding for the A. nidu-
lans pyroA gene, flanked by 1 kb sequences representing DNA up- and
downstream of tdiA and tdiD, respectively. PyroA complements the
vitamine B6-auxotrophic phenotype of A. nidulans strains rNI773 and
TN02A7.
For tdiA inactivation, primer pairs tdiBF2/tdiBR2 for the 50 flanking
region and tdiBF1/tdiBR1 for the 30 flank (which includes about
0.5 kb of the 30 portion of the tdiA reading frame) were designed for
PCR from chromosomal A. nidulans DNA. For tdiD flanking regions,
primer pairs tdiEF1/tdiER1 and tdiEF2/tdiER2 were used. All primer se-
quences are listed in Table S2.Pfu-DNA polymerase was used for PCR
amplification. 50 flanks were cloned between the EcoRI/BamHI sites
(for the tdiD construct), and between EcoRI/KpnI (for tdiA), the 30 flank-
ing regions were ligated to the PstI/HindIII sites of plasmid p14 [46].
The DNA of flanking regions was checked by DNA sequencing.
The resulting plasmids were pKR1 for tdiA, and pKR2 for tdiD disrup-
tion. Linear gene disruption cassettes were obtained by releasing them
from plasmids pKR1 or pKR2, by EcoRI/HindIII corestriction, followed
by purification on an agarose gel. This DNA was used to transform
A. nidulans. For tdiA inactivation, strain rNI773 [10] was used; tdiD
was inactivated in TN02A7 [47]. Protoplast transformation of either
strain followed standard protocols [10]. For each gene inactivation,
about 50 transformants were prescreened by PCR for the gene
replacement event. Chromosomal DNA from transformants was
used to amplify the manipulated region by using the primer pairs
tdiBF1/tdiBR2 for tdiA and tdiEF1/tdiER2 for tdiD. Putative positives
were confirmed by Southern hybridization and HPLC-based natural
product analysis. Strains TMW1.2 (DtdiA) and TMW3.7 (DtdiD) were
used for further study.
To revert terrequinone A production to wild-type level in A. nidulans
TMW3.7, this strain was complemented by transformation with plas-
mid pMW9, which carries a functional tdiD allele and complements
uracil/uridine auxotrophy with the Neurospora crassa pyr-4 gene as
selection marker. To construct pMW9, a 3.5 kb PCR fragment (coding
for tdiD and up- and downstream sequences) was amplified from chro-
mosomal A. nidulans DNA by using the primer pair tdiEF1/tdiER2 and
Pfu-DNA-polymerase. This fragment was restricted EcoRI/EcoRV and
ligated to pBluescript (Stratagene) cut EcoRI/SmaI to create pMW8.
DNA sequencing confirmed error-free amplification during PCR. The
insert was removed from pMW8 by EcoRI/XbaI corestriction, and
ligated to plasmid pMR18 (M. Reis and R. Fischer, personal communi-
cation), restricted equally, to yield pMW9. A. nidulans transformants
were selected by culturing on GMM, supplemented with riboflavin
(2.5 mg/l).
cDNA Cloning
The SV total RNA isolation system (Promega) was used to purify total
RNA from A. nidulans TN02A7, grown under terrequinone-inducing
conditions. First-strand cDNA synthesis was accomplished by using
25 pmol DNA-primer tdiB-CF1, 2.5 mM MgCl2, 0.5 mM each dNTP,
and ImProm reverse transcriptase (Promega). This was followed by
a standard PCR reaction: 2.5 mM MgCl2, 0.2 mM each dNTP,642 Chemistry & Biology 14, 635–644, June 2007 ª2007 Elsevier40 pmol (each) primers tdiB-CF1 and tdiB-CR2, first-strand reaction
as template, and 4U Pfu DNA-polymerase (Promega) in the buffer sup-
plied with the enzyme, in a total volume of 100 ml with the following
thermocycling parameters: initial denaturation, 2 min, 94C; amplifica-
tion, 35 cycles (94C for 40 s, 62C for 30 s, 72C for 9 min); terminal
hold, 8 min at 72C. PCR products were electrophoretically separated
on an agarose gel, and the desired bands excised, recovered with the
Nucleospin Extract Kit (Macherey-Nagel), and ligated to the NdeI/
EcoRI sites of pET28b (Novagen), to create pDH9. The insert was se-
quenced. Cloning of tdiD-cDNA followed essentially the same strategy
but with primer tdiE-CF for first-strand synthesis and primer pair tdiE-
CF/tdiE-CR for PCR for which the elongation time was set to 4 min.
Cloning tdiD-cDNA to pET28b created pDH8.
Enzyme Overexpression and Purification
E. coli BL21(DE3)3 pLysS (Stratagene) was transformed with pDH8 to
produce His6-tagged protein TdiD. One milliliter of an overnight culture
in LB-medium, amended with chloramphenicol (30 mg/l) and carbeni-
cillin (50 mg/l), was used to inoculate 100 ml of the same medium. The
culture was incubated at 37C on an orbital shaker at 180 rpm. The
expression was induced by addition of 0.4 mM IPTG at an OD600 of
0.7, for 4 hr at 28C, before collecting the biomass by centrifugation
(4C, 1,200 3 g, 15 min). The cells were resuspended in lysis buffer
(Na2HPO4/NaH2PO4 50mM, NaCl 300mM, imidazole 10 mM [pH 8.0])
and disrupted by passing the material twice through a French pressure
cell (Thermo Scientific) at 16,000 psi working pressure. Cellular debris
was removed by centrifugation at 4C, 14,0003 g, for 15 min. The pro-
tein was purified by Ni-NTA (QIAGEN) affinity chromatography carried
out following the QIAexpressionist manual. The pure enzyme was
desalted on a PD-10 column (GE Healthcare) equilibrated with
100 mM Tris-Buffer (pH 7.5). The purification process was verified by
SDS-Page analysis (12% Laemmli gels). The protein concentration
was determined by the method of Bradford [48]. The identical proce-
dure was applied for TdiA purification, except that induced bacterial
cultures were maintained at room temperature. Purified enzymes
were used for biochemical characterizations as described below.
Biochemical Characterization of TdiA
All reactions were run in triplicate. Adenylation domain: the TdiA
adenylation domain was investigated by using the ATP-PPi-exchange
assay: it was carried out in a total volume of 100 ml at 42C (varied from
4C to 70C to determine the temperature optimum) containing
100 mM Tris-HCl or phosphate buffers (pH 6.5) (varied from pH 5.7
to 8.0 used to determine the pH optimum), 6.25 mM MgCl2, 125 mM
EDTA, 6.25 mM ATP, 100 nM purified TdiA, 0.1 mM [32P]-pyrophos-
phate, and 1 mM indole-3-pyruvic acid. After incubating for 20 min,
the reaction was stopped and further processed as described [49].
Phosphopantetheinylation of TdiA: Apo-TdiA was converted to the
holo-enzyme in vivo by using the Streptomyces verticillus Ppant trans-
ferase Svp encoded on plasmid pBS18 [19]. E.coli BL21(DE3)3 pLysS
was transformed with pDH8 and pBS18. The enzyme was expressed
and purified as described for TdiA, followed by an additional size-
exclusion filtration step with a Sartorius Vivaspin centrifugation device
(cut-off limit 50 kDa) to remove Svp from the enzyme preparation.
Formation of didemethylasterriquinone D was accomplished in
a 500 ml reaction set up as follows: 100 mM Tris-HCl (pH 6.5),
6.25 mM MgCl2, 125 mM EDTA, 6.25 mM ATP, 100 nM purified holo-
TdiA, and 1 mM indole-3-pyruvic acid, at 42C, for 20 min (or various
time points to record enzyme kinetics). Product formation was ob-
served by HPLC analysis with gradient 1 (see below) and LC/MS.
Biochemical Characterization of TdiD
The enzyme assay was performed in a reaction mixture containing
1 mM L-tryptophan, 2 mM phenylpyruvate (or 2-oxobutyric acid,
2-ketoglutatate, oxaloacetate, p-hydroxyphenylpyruvate, or pyru-
vate), 0.5 mM pyridoxal phosphate, 100 mM Tris-HCl or phosphate
buffers (pH 7.0) (or pH 5.7 to 8.0 to determine the pH optimum), and
10 nM purified enzyme. The incubation was carried out at 48C (4CLtd All rights reserved
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different time points for recording enzyme kinetics) by snap freezing
the sample in liquid nitrogen. The conversion to indole-3-pyruvate
was monitiored by HPLC analysis with gradient 2 (see below) and
LC/MS.
One-Pot Coupled Reaction TdiD-TdiA
The coupled reaction was performed in a mixture containing 100 mM
Tris-HCl buffer (pH 6.5), 5 mM L-tryptophan, 10 mM phenylpyruvate,
10 mM ATP, 10 mM MgCl2, 0.25 mM EDTA, and 0.5 mM pyridoxal
phosphate. After incubating the mixture for 5 min at 42C with 10 nM
purified TdiD, purified holo-TdiA (10 nM) was added and incubated
for another 25 min. The two-step conversion of L-tryptophan to di-
demethylasterrequinone D was verified by HPLC (gradient 1) and
LC/MS. Authentic substance (kindly provided by Drs. Frank Petersen
and Philipp Krastel, Natural Products Unit, Novartis Pharma AG, Basel,
Switzerland) served as reference.
HPLC Analyses of Enzyme Assays
HPLC runs to analyze enzyme assays described above were perfomed
on a Waters liquid chromatograph equipped with an Xbridge MS C-18
column (1003 4.6 mm) and a C-18 guard column at 35C: detection at
280 nm (diode array acquisition: 220–500 nm). Solvent A was water,
solvent B acetonitrile. Two standard gradients (both at a flow rate of
0.8 ml/min) were applied. Gradient 1 was: within 2 min from 5% B to
35% B, within 10 min to 55% B, and then to 95% B within 2 min. Gra-
dient 2 was: within 10 min from 5% to 10% B, followed by a ramp up to
95% B within 2 min. Analytical liquid chromatography-mass spectros-
copy (LC/MS) was done on an Agilent 1100 integrated system equip-
ped with a Zorbax Eclipse XDB C-8 column (150 3 4.6 mm, 5 mm
particle size) and C-8 guard column essentially running the gradients
described above. Mass spectrometry was performed with atmo-
spheric pressure chemical ionization (APCI) in positive and negative
mode and applying a capillary voltage of U = 3kV.
Aspergillus Natural Product Analysis
A. nidulans TMW1.2, TMW3.7, TMW8.3, as well as rNI773 or TN02A7
for reference were grown in 100 ml glucose minimal medium, dis-
pensed into 300 ml Erlenmeyer flasks, and supplemented appropri-
ately. The cultures were fermented at 37C and 200 rpm, for 3 days. To
determine differences in terrequinone A production between TMW8.3
and TN02A7, strains were cultivated and analyzed in triplicate. Upon
harvest, the fermentation broth was centrifuged (10 min, 2,700 3 g).
The biomass was discarded. The supernatant was extracted with an
equal volume of chloroform, and the organic layer evaporated in vacuo
and then redissolved in 300 ml methanol and subjected to high per-
formance liquid chromatography (HPLC). Analytical HPLC was per-
formed on the equipment and solvents described above applying the
following gradient: initial hold for 1 min at 45% B, within 3 min to
65% B, and then to 95% B within 10 min, at a flow rate of 0.5 ml/min.
Supplemental Data
Supplemental Data include genotypes of Aspergillus strains used
during this study and oligonucleotide primer sequences and are avail-
able at http://www.chembiol.com/cgi/content/full/14/6/635/DC1/.
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